References
AMINIAN, K., MASHAYEKHI, F.,
MIRZANEJAD, L. & SALEHI, Z. 2019. A functional genetic variant in GAS5
lncRNA (rs145204276) modulates p27(Kip1) expression and confers risk for
gastric cancer. J Cell Physiol, 76, 83-85.
BARTONICEK, N., MAAG, J. L. & DINGER,
M. E. 2016. Long noncoding RNAs in cancer: mechanisms of action and
technological advancements. Molecular cancer, 15, 43.
BHAN, A. & MANDAL, S. S. 2014. Long
noncoding RNAs: emerging stars in gene regulation, epigenetics and human
disease. ChemMedChem, 9, 1932-1956.
BROSNAN, C. A. & VOINNET, O. 2009.
The long and the short of noncoding RNAs. Current opinion in cell
biology, 21, 416-425.
CAO, S., LIU, W., LI, F., ZHAO, W. &
QIN, C. 2014. Decreased expression of lncRNA GAS5 predicts a poor
prognosis in cervical cancer. International journal of clinical
and experimental pathology, 7, 6776.
CHEETHAM, S., GRUHL, F., MATTICK, J.
& DINGER, M. 2013. Long noncoding RNAs and the genetics of cancer.British journal of cancer, 108, 2419.
CHEN, G., WANG, Z., WANG, D., QIU, C.,
LIU, M., CHEN, X., ZHANG, Q., YAN, G. & CUI, Q. 2012. LncRNADisease: a
database for long-non-coding RNA-associated diseases. Nucleic
acids research, 41, D983-D986.
FOROUZANFAR, M. H., AFSHIN, A.,
ALEXANDER, L. T., ANDERSON, H. R., BHUTTA, Z. A., BIRYUKOV, S., BRAUER,
M., BURNETT, R., CERCY, K. & CHARLSON, F. J. 2016. Global, regional,
and national comparative risk assessment of 79 behavioural,
environmental and occupational, and metabolic risks or clusters of
risks, 1990–2015: a systematic analysis for the Global Burden of
Disease Study 2015. The Lancet, 388, 1659-1724.
GOTO, Y., KOJIMA, S., NISHIKAWA, R.,
ENOKIDA, H., CHIYOMARU, T., KINOSHITA, T., NAKAGAWA, M., NAYA, Y.,
ICHIKAWA, T. & SEKI, N. 2014. The microRNA-23b/27b/24-1 cluster is a
disease progression marker and tumor suppressor in prostate cancer.Oncotarget, 5, 7748.
GU, J., WANG, Y., WANG, X., ZHOU, D.,
SHAO, C., ZHOU, M. & HE, Z. 2018. Downregulation of lncRNA GAS5 confers
tamoxifen resistance by activating miR-222 in breast cancer.Cancer letters, 434, 1-10.
GUO, Z., WANG, Y., ZHAO, Y., JIN, Y.,
AN, L., WU, B., LIU, Z., CHEN, X., ZHOU, H. & WANG, H. 2017. Genetic
polymorphisms of long non-coding RNA GAS5 predict platinum-based
concurrent chemoradiotherapy response in nasopharyngeal carcinoma
patients. Oncotarget, 8, 62286.
GUPTA, R. A., SHAH, N., WANG, K. C.,
KIM, J., HORLINGS, H. M., WONG, D. J., TSAI, M.-C., HUNG, T., ARGANI, P.
& RINN, J. L. 2010. Long non-coding RNA HOTAIR reprograms chromatin
state to promote cancer metastasis. Nature, 464, 1071.
HOSEINI, B. L., SAEIDI, M., VAKILI,
R., KIANI, M., RABIEI, M., KHAKSHOUR, A. & RASTI SANI, S. J. I. J. O.
P. 2014. Assessment the Relationship between Parents’ Literacy Level
with Children Growth in Mashhad: An Analytic Descriptive Study.
2, 59-59.
HOSSEINI, M., SAHEBI, R.,
AGHASIZADEH, M., YAZDI, D. F., SALARIBAGHOONABAD, R., GODSI, A.,
SOFLAEI, S. S., MOUSAVITAHERABAD, S. P., AHMADIHOSEINI, A. & BAJGIRAN,
M. M. J. G. R. 2022. Investigating the predictive value of microRNA21 as
a biomarker in induced myocardial infarction animal model. 27,101578.
HU, G., YANG, T., ZHENG, J., DAI, J.,
NAN, A., LAI, Y., ZHANG, Y., YANG, C. & JIANG, Y. 2015. Functional role
and mechanism of lncRNA LOC728228 in malignant 16HBE cells transformed
by anti‐benzopyrene‐trans‐7, 8‐dihydrodiol‐9, 10‐epoxide.Molecular carcinogenesis, 54.
KONG, H., WU, Y., ZHU, M., ZHAI, C.,
QIAN, J., GAO, X., WANG, S., HOU, Y., LU, S. & ZHU, H. 2016. Long
non-coding RNAs: novel prognostic biomarkers for liver metastases in
patients with early stage colorectal cancer. Oncotarget,7, 50428.
KONG, X.-P., YAO, J., LUO, W., FENG,
F.-K., MA, J.-T., REN, Y.-P., WANG, D.-L. & BU, R.-F. 2014. The
expression and functional role of a FOXC1 related mRNA-lncRNA pair in
oral squamous cell carcinoma. Molecular and cellular
biochemistry, 394, 177-186.
LI, Q., MA, G., GUO, H., SUN, S., XU,
Y. & WANG, B. 2018a. The Variant rs145204276 of GAS5 is Associated with
the Development and Prognosis of Gastric Cancer. Journal of
gastrointestinal and liver diseases: JGLD, 27, 19-24.
LI, Q., MA, G., GUO, H., SUN, S., XU,
Y. & WANG, B. 2018b. The variant rs145204276 of GAS5 is associated with
the development and prognosis of gastric cancer. Journal of
Gastrointestinal and Liver Diseases, 27, 19-24.
LI, Q., MA, G., SUN, S., XU, Y. &
WANG, B. 2018c. Polymorphism in the promoter region of lncRNA GAS5 is
functionally associated with the risk of gastric cancer. Clinics
and research in hepatology and gastroenterology .
LI, W., HUANG, K., WEN, F., CUI, G.,
GUO, H. & ZHAO, S. 2017. Genetic variation of lncRNA GAS5 contributes
to the development of lung cancer. Oncotarget, 8, 91025.
LING, H., VINCENT, K., PICHLER, M.,
FODDE, R., BERINDAN-NEAGOE, I., SLACK, F. J. & CALIN, G. A. 2015. Junk
DNA and the long non-coding RNA twist in cancer genetics.Oncogene, 34, 5003.
MARTORELL-MARUGAN, J.,
TORO-DOMINGUEZ, D., ALARCON-RIQUELME, M. E. & CARMONA-SAEZ, P. 2017.
MetaGenyo: a web tool for meta-analysis of genetic association studies.BMC bioinformatics, 18, 563.
MCGUIRE, S. 2016. World cancer report
2014. Geneva, Switzerland: World Health Organization, international
agency for research on cancer, WHO Press, 2015. Advances in
Nutrition: An International Review Journal, 7, 418-419.
MOURTADA-MAARABOUNI, M., PICKARD, M.,
HEDGE, V., FARZANEH, F. & WILLIAMS, G. 2009. GAS5, a non-protein-coding
RNA, controls apoptosis and is downregulated in breast cancer.Oncogene, 28, 195.
OGINO, S., SHIMA, K., NOSHO, K.,
IRAHARA, N., BABA, Y., WOLPIN, B. M., GIOVANNUCCI, E. L., MEYERHARDT, J.
A. & FUCHS, C. S. 2009. A cohort study of p27 localization in colon
cancer, body mass index, and patient survival. Cancer Epidemiology
and Prevention Biomarkers, 18, 1849-1858.
OLDONI, F., PALMEN, J.,
GIAMBARTOLOMEI, C., HOWARD, P., DRENOS, F., PLAGNOL, V., HUMPHRIES, S.
E., TALMUD, P. J. & SMITH, A. J. J. A. 2016. Post-GWAS methodologies
for localisation of functional non-coding variants: ANGPTL3.
246, 193-201.
PAN, W., LIU, L., WEI, J., GE, Y.,
ZHANG, J., CHEN, H., ZHOU, L., YUAN, Q., ZHOU, C. & YANG, M. 2016. A
functional lncRNA HOTAIR genetic variant contributes to gastric cancer
susceptibility. Molecular carcinogenesis, 55, 90-96.
RASHIDMAYVAN, M., KHORASANCHI, Z.,
NATTAGH‐ESHTIVANI, E., ESFEHANI, A. J., SAHEBI, R., SHARIFAN, P.,
ASSADIAN, P., AGHASIZADEH, M., AVAN, A., GHAYOUR‐MOBARHAN, M. J. M. N.
& RESEARCH, F. 2022. Association between inflammatory factors, vitamin
D, long non‐coding RNAs, MALAT1 and Adiponectin antisense in individuals
with metabolic syndrome. 2200144.
SCHMIDT, L. H., SPIEKER, T.,
KOSCHMIEDER, S., HUMBERG, J., JUNGEN, D., BULK, E., HASCHER, A.,
WITTMER, D., MARRA, A. & HILLEJAN, L. 2011. The long noncoding MALAT-1
RNA indicates a poor prognosis in non-small cell lung cancer and induces
migration and tumor growth. Journal of thoracic oncology,6, 1984-1992.
SIEGEL, R. L., MILLER, K. D. &
JEMAL, A. 2015. Cancer statistics, 2015. CA: a cancer journal for
clinicians, 65, 5-29.
SMITH, C. M. & STEITZ, J. A. 1998.
Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene
and a member of the 5′-terminal oligopyrimidine gene family reveals
common features of snoRNA host genes. Molecular and cellular
biology, 18, 6897-6909.
SUN, M., JIN, F.-Y., XIA, R., KONG,
R., LI, J.-H., XU, T.-P., LIU, Y.-W., ZHANG, E.-B., LIU, X.-H. & DE, W.
2014. Decreased expression of long noncoding RNA GAS5 indicates a poor
prognosis and promotes cell proliferation in gastric cancer. BMC
cancer, 14, 319.
TANG, Y., WANG, Y., WANG, X., LIU, Y.
& ZHENG, K. 2019. A Genetic Variant of rs145204276 in the Promoter
Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of
Breast Cancer. Biosci Rep, 19, e415-e421.
TAO, R., HU, S., WANG, S., ZHOU, X.,
ZHANG, Q., WANG, C., ZHAO, X., ZHOU, W., ZHANG, S., LI, C., ZHAO, H.,
HE, Y., ZHU, S., XU, J., JIANG, Y., LI, L. & GAO, Y. 2015. Association
between indel polymorphism in the promoter region of lncRNA GAS5 and the
risk of hepatocellular carcinoma. Carcinogenesis, 36,1136-43.
TU, Z.-Q., LI, R.-J., MEI, J.-Z. &
LI, X.-H. 2014. Down-regulation of long non-coding RNA GAS5 is
associated with the prognosis of hepatocellular carcinoma.International journal of clinical and experimental pathology,7, 4303.
XU, L., XIA, C., XUE, B., SHENG, F.,
XIONG, J. & WANG, S. 2018. A promoter variant of lncRNA GAS5 is
functionally associated with the development of osteosarcoma.Journal of Bone Oncology, 12, 23-26.
YAN, H., ZHANG, D.-Y., LI, X., YUAN,
X.-Q., YANG, Y.-L., ZHU, K.-W., ZENG, H., LI, X.-L., CAO, S. & ZHOU,
H.-H. 2017. Long non-coding RNA GAS5 polymorphism predicts a poor
prognosis of acute myeloid leukemia in Chinese patients via affecting
hematopoietic reconstitution. Leukemia & lymphoma, 58,1948-1957.
YANG, F., BI, J., XUE, X., ZHENG, L.,
ZHI, K., HUA, J. & FANG, G. 2012. Up‐regulated long non‐coding RNA H19
contributes to proliferation of gastric cancer cells. The FEBS
journal, 279, 3159-3165.
YUAN, J., ZHANG, N., ZHENG, Y., CHEN,
Y.-D., LIU, J. & YANG, M. 2018. LncRNA GAS5 Indel Genetic Polymorphism
Contributes to Glioma Risk Through Interfering Binding of
Transcriptional Factor TFAP2A. DNA and cell biology, 37,750-757.
ZHANG, F., ZHANG, L. & ZHANG, C.
2016. Long noncoding RNAs and tumorigenesis: genetic associations,
molecular mechanisms, and therapeutic strategies. Tumor Biology,37, 163-175.
ZHENG, Y., SONG, D., XIAO, K., YANG,
C., DING, Y., DENG, W. & TONG, S. 2016. LncRNA GAS5 contributes to
lymphatic metastasis in colorectal cancer. Oncotarget,7, 83727.
ZHU, Z., FENG, L., LI, F., XUE, Y.,
LI, C. & WANG, H. 2017. A novel functional indel polymorphism within
long non-coding RNAs growth arrest specific 5 conferred risk for
cervical squamous cell carcinoma in Chinese Han populations.Translational Cancer Research, 6, 424-431.
ZHU, Z., XUE, Y., FU, W., LI, C.,
FENG, L., XING, Y. & WANG, H. 2016. Functional indel polymorphism
within lncRNA GAS5 and colorectal carcinoma risk. International
Journal of Clinical and Experimental Pathology, 9,11767-11773.
ZHUANG, Y., YIN, H.-T., YIN, X.-L.,
WANG, J. & ZHANG, D.-P. 2011. High p27 expression is associated with a
better prognosis in East Asian non-small cell lung cancer patients.Clinica chimica acta, 412, 2228-2231.
Table 1: Characteristics of the eligible studies included in the
meta-analysis.